Literature DB >> 15213184

Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan.

Eva Mattsson1, Thomas Hartung, Siegfried Morath, Arne Egesten.   

Abstract

Lipoteichoic acid from Staphylococcus aureus was a potent inducer of procoagulant activity in isolated mononuclear cells but not in whole blood. In contrast, staphylococcal peptidoglycan showed equal levels of potency in isolated mononuclear cells and whole blood, suggesting that peptidoglycan is an important inducer of procoagulant activity in severe sepsis involving gram-positive bacteria.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15213184      PMCID： PMC427414          DOI： 10.1128/IAI.72.7.4322-4326.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  24 in total

1.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

2.  Synergistic septicemic action of the gram-positive bacterial cell wall components peptidoglycan and lipoteichoic acid in the pig in vivo.

Authors:  R J Middelveld; K Alving
Journal:  Shock       Date:  2000       Impact factor: 3.454

3.  Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model.

Authors:  J E Wang; P F Jørgensen; M Almlöf; C Thiemermann; S J Foster; A O Aasen; R Solberg
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock.

Authors:  J Cohen; E Abraham
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

5.  Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.

Authors:  Siegfried Morath; Armin Geyer; Ingo Spreitzer; Corinna Hermann; Thomas Hartung
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages.

Authors:  M A Cunningham; P Romas; P Hutchinson; S R Holdsworth; P G Tipping
Journal:  Blood       Date:  1999-11-15       Impact factor: 22.113

7.  Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytes.

Authors:  Eva Mattsson; Heiko Herwald; Lars Björck; Arne Egesten
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

8.  Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.

Authors:  Espen Ellingsen; Siegfried Morath; Trude Flo; Andra Schromm; Thomas Hartung; Christoph Thiemermann; Terje Espevik; Douglas Golenbock; Daniel Foster; Rigmor Solberg; Ansgar Aasen; Jacob Wang
Journal:  Med Sci Monit       Date:  2002-05

9.  The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis.

Authors:  S M Opal; J E Palardy; N A Parejo; A A Creasey
Journal:  Crit Care Med       Date:  2001-01       Impact factor: 7.598

10.  Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus.

Authors:  S Morath; A Geyer; T Hartung
Journal:  J Exp Med       Date:  2001-02-05       Impact factor: 14.307
View more
  7 in total

1.  Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.

Authors:  Narcis Ioan Popescu; Alanson Girton; Tarea Burgett; Kessa Lovelady; K Mark Coggeshall
Journal:  Blood Adv       Date:  2019-08-27

2.  Comparison of the interleukin-1β-inducing potency of allergenic spores from higher fungi (basidiomycetes) in a cryopreserved human whole blood system.

Authors:  Félix E Rivera-Mariani; Kranthi Vysyaraju; Jesse Negherbon; Estelle Levetin; W Elliot Horner; Thomas Hartung; Patrick N Breysse
Journal:  Int Arch Allergy Immunol       Date:  2013-12-17       Impact factor: 2.749

3.  Inflammatory cytokine response to Bacillus anthracis peptidoglycan requires phagocytosis and lysosomal trafficking.

Authors:  Janaki K Iyer; Taruna Khurana; Marybeth Langer; Christopher M West; Jimmy D Ballard; Jordan P Metcalf; Tod J Merkel; K Mark Coggeshall
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

4.  Bacterial lipoteichoic acid enhances cryosurvival.

Authors:  Charles V Rice; Amy Middaugh; Jason R Wickham; Anthony Friedline; Kieth J Thomas; Erin Scull; Karen Johnson; Malcolm Zachariah; Ravindranth Garimella
Journal:  Extremophiles       Date:  2014-12-05       Impact factor: 2.395

5.  Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.

Authors:  Matthew R Kimbrell; Hemamali Warshakoon; Jens R Cromer; Subbalakshmi Malladi; Jennifer D Hood; Rajalakshmi Balakrishna; Tandace A Scholdberg; Sunil A David
Journal:  Immunol Lett       Date:  2008-04-18       Impact factor: 3.685

6.  Staphylococcal endocarditis presenting with a renal infarct in a patient with acute lymphoblastic leukemia.

Authors:  Meong Hi Son; Eun Sil Park; Ji-Hyun Seo; Jae-Young Lim; Chan-Hoo Park; Hyang-Ok Woo; Hee-Shang Youn
Journal:  Cancer Res Treat       Date:  2008-09-30       Impact factor: 4.679

7.  Staphylococcus aureus induces a muted host response in human blood that blunts the recruitment of neutrophils.

Authors:  Erin E Zwack; Ze Chen; Joseph C Devlin; Zhi Li; Xuhui Zheng; Ada Weinstock; Keenan A Lacey; Edward A Fisher; David Fenyö; Kelly V Ruggles; P'ng Loke; Victor J Torres
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-26       Impact factor: 12.779
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.